Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Obesity 1

Interventions

Metformin 17Liraglutide 5semaglutide 3Exercise 3Exenatide 3Diet, Mediterranean 3Dexamethasone 3Caloric Restriction 3Ovidrel 2Mindfulness-Based Stress Reduction 2Hydrocortisone 2Electroacupuncture 2Docosahexaenoic Acids 2Diet 2Cosyntropin 2sibutramine 1penclomedine 1mirabegron 1lime 1licogliflozin 1dapagliflozin 1Vitamin D 1Utrogestan 1Topiramate 1Tirzepatide 1Therapeutics 1Testosterone 1Surveys and Questionnaires 1Standard of Care 1Spironolactone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × dapagliflozin × Other × Clear all
NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed
119 enrolled 34 charts
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡